BCL2 and neoplasm: Eventually, the tumor growthin the experimental group (Bcl-2-SNA) was almost completely inhibited,and the tumor inhibition rate was as high as 95% (Figure 3B), which proved the huge prospectsfor cancer treatment by controlling cell apoptosis.